A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...
Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.